Board of Pharmacy to Offer Controlled Substance Disposal Locations to the Public
The Board of Pharmacy has provided an opportunity for North Dakota pharmacies to offer a drug disposal program. Participating pharmacies are providing access to a secure and safe way to dispose of controlled substances for their patients. This will provide a mechanism to reduce the amount of medications in a patient's residence to assure they are not diverted or misused. Information about participating pharmacy locations along with the ND Attorney General's Take Back program location can be accessed at the following link: Disposal location options. For North Dakota pharmacies: Please contact the Board office if you are interested in offering this service.
Board of Pharmacy to hold Public Rule Hearing on April 6th, 2019
April 2019 Rules – Drafts revised as of June 24th
- Full Notice (539 KB PDF)
- Abbreviated Notice (134 KB PDF)
- 61-01-01-01- Organization of Board of Pharmacy (192 KB PDF)
- 61-02-01-03 - Pharmaceutical Compounding Standards (221 KB PDF)
- 61-02-02-01 - Building Standards for Pharmacies (197 KB PDF)
- 61-02-04-02 - Handling of Hazardous Drugs (598 KB PDF)
- 61-02-06-02 - Computer Pharmacy Regulations (190 KB PDF)
- 61-02-07.1-03 - Pharmacy Technician Education preparation (196 KB PDF)
- 61-02-07.1-04 - Pharmacy Technician (196 KB PDF)
- 61-02-07.1-10 - Pharmacy Technician Continuing Education (196 KB PDF)
- 61-03-02-04 - Consultant Pharmacist Regulations for LTC Facility (202 KB PDF)
- 61-03-03.1-01 - Internship (193 KB PDF)
- 61-03-04-02 - Pharmacist Continuing Education (195 KB PDF)
- 61-03-04-04 - CE Advisory Board (195 KB PDF)
- 61-04-03-01 - Destruction of Controlled Substances (188 KB PDF)
- 61-08-01-08 - Out-of-State Pharmacy Inspection (195 KB PDF)
- 61-08-01-09 - Out-of-State Pharmacy (195 KB PDF)
- 61-12-01-03 - Prescription Drug Monitoring Program [PDMP] (197 KB PDF)
- 61-12-01-04 - Prescription Drug Monitoring Program [PDMP] (197 KB PDF)
- 61-13-01-03 - Controlled Substances Schedules (271 KB PDF)
- Regulatory Analysis (491 KB PDF)
- Small Entity Economic Impact and Regulatory Statement (674 KB PDF)
- Fiscal Note (664 KB PDF)
The "Red Flags" video helps pharmacists identify warning signs of prescription
drug abuse and diversion. If the video
above does not play, please click here to access the video.
Durable Medical Equipment Licensure for North Dakota Required by August 1, 2013
Durable Medical Equipment Licensure for North Dakota Required by August 1, 2013 - click here for details.
Click here for SB 2342 which includes the licensing requirements.
Obtaining a NPLEx Account
If your pharmacy sells ephedrine and/or pseudoephedrine over the counter, you will need to request access to the National Precursor Log Exchange (NPLEx) by visiting www.NPLExSurvey.com. Please click on the appropriate state and complete the survey for an NPLEx account. Once your account has been verified, you will be contacted by Appriss, provider of NPLEx, to inform you of next steps.
DEA Issues Statement on Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies
The Drug Enforcement Administration (DEA) has issued a statement of policy to provide guidance under existing law regarding the proper role of a duly authorized agent of a DEA-registered individual practitioner in connection with the communication of a controlled substance prescription to a pharmacy.
For more information and a sample of the Designated Agent to Communicate Controlled Substance Prescriptions to Pharmacies form, please click here.
NDSU CE Survey
Help NDSU determine what CE programs you would like. Please click here to fill out the survey.
The Board of Pharmacy protects, preserves and promotes the public health and welfare of the citizens of North Dakota by assuring that the highest quality pharmaceutical care is delivered and that appropriate use of pharmaceuticals is upheld through education, communication, licensing, legislation, regulation, and enforcement.
Pharmacy is a service profession. The philosophy of pharmaceutical care focuses on the patient as the beneficiary of pharmacists' activities. The responsible provision of pharmaceutical therapy for the purpose of achieving definite outcomes is intended to improve patient's quality of life.
Our profession acknowledges and pursues the highest ethical standards in all endeavors. Honesty and integrity guide all interactions with patients, other healthcare practitioners, and the general public.
Our profession requires that pharmacists possess the knowledge and skills to practice pharmacy as contemporarily defined.
A profession that is recognized as primary healthcare provider capable of responding to society’s healthcare needs.here